+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Advanced Therapy Medicinal Products - Global Strategic Business Report

  • PDF Icon

    Report

  • 436 Pages
  • July 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5301748
The global market for Advanced Therapy Medicinal Products is estimated at US$10.8 Billion in 2023 and is projected to reach US$24 Billion by 2030, growing at a CAGR of 10.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Tissue Engineered Products segment, which is expected to reach US$10 Billion by 2030 with a CAGR of 11.2%. The Cell Therapy segment is also set to grow at 10% CAGR over the next 8 years.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $4.8 Billion in 2023, and China, forecasted to grow at an impressive 9.1% CAGR to reach $1.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Advanced Therapy Medicinal Products Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Advanced Therapy Medicinal Products Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Advanced Therapy Medicinal Products Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Bluebird Bio Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 190 Featured):

  • Bluebird Bio Inc.
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • JCR Pharmaceuticals Co. Ltd.
  • Kolon TissueGene, Inc.
  • MEDIPOST Co., Ltd.
  • Novartis AG
  • Organogenesis Inc.
  • Spark Therapeutics, Inc.
  • UniQure N.V.
  • Vericel Corporation

MarketGlass Platform

Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • A Prelude to Advanced Therapy Medicinal Products (ATMP)
  • ATMPs' Costs and Availability
  • Global Economic Outlook
  • Global Market Prospects and Outlook
  • Advanced Therapy Medicinal Products Market Poised to Witness Rapid Growth
  • Growth Drivers and Challenges
  • ATMP Marketing Authorisations: An Insight
  • North America and Europe Dominate, Asia-Pacific to Exhibit Fastest Growth
  • Competition
  • Recent Market Activity
  • Advanced Therapy Medicinal Products - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Geriatric Population and Subsequent Growth in Prevalence of Neurological Disorders Drive Market Demand
  • Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Regenerative Medicine: A Promising Area for Advanced Therapy Medicinal Products
  • Global Regenerative Medicine Market Size in US$ Billion for 2019, 2021, 2023 and 2025
  • Global Regenerative Medicines Market by Category: Breakdown (in %) for Biomaterials, Stem Cell Therapies and Tissue Engineering for 2022
  • Stem Cell Therapy: A Promising Avenue for Nerve Repair and Regeneration
  • Rising Demand for Gene Therapy Spurs Market Expansion
  • List of Genetic Disorders by Event, Genetic Manifestation and Prevalence
  • Top Ten Genetic Diseases Worldwide
  • Oncology Represents the Largest Indication for Gene Therapy
  • Uptrend in Healthcare Spending Creates Fertile Environment
  • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
  • Expanding Role of Advanced Therapy Medicinal Products Market in Personalized Medicine
  • Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
  • World Personalized Medicine Market by Region/Country (2022): Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific and Rest of World
  • Biotech Research Spending Patterns Steer Momentum
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Advanced Therapy Medicinal Products Market Analysis of Annual Sales in US$ Million for Years 2022 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 3: World 7-Year Perspective for Advanced Therapy Medicinal Products by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Tissue Engineered Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 5: World 7-Year Perspective for Tissue Engineered Products by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 6: World Recent Past, Current & Future Analysis for Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 7: World 7-Year Perspective for Cell Therapy by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 9: World 7-Year Perspective for Gene Therapy by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for CAR-T Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 11: World 7-Year Perspective for CAR-T Therapy by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 12: USA Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 13: USA 7-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2024 & 2030
CANADA
  • Table 14: Canada Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 15: Canada 7-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2024 & 2030
JAPAN
  • Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 16: Japan Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 17: Japan 7-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2024 & 2030
CHINA
  • Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 18: China Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 19: China 7-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2024 & 2030
EUROPE
  • Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 20: Europe Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 21: Europe 7-Year Perspective for Advanced Therapy Medicinal Products by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
  • Table 22: Europe Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 23: Europe 7-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2024 & 2030
FRANCE
  • Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 24: France Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 25: France 7-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2024 & 2030
GERMANY
  • Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 26: Germany Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 27: Germany 7-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2024 & 2030
ITALY
  • Table 28: Italy Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 29: Italy 7-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2024 & 2030
UNITED KINGDOM
  • Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 30: UK Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 31: UK 7-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2024 & 2030
REST OF EUROPE
  • Table 32: Rest of Europe Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 33: Rest of Europe 7-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2024 & 2030
ASIA-PACIFIC
  • Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 34: Asia-Pacific Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 35: Asia-Pacific 7-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2024 & 2030
REST OF WORLD
  • Table 36: Rest of World Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 37: Rest of World 7-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2024 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Bluebird Bio Inc.
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • JCR Pharmaceuticals Co. Ltd.
  • Kolon TissueGene, Inc.
  • MEDIPOST Co., Ltd.
  • Novartis AG
  • Organogenesis Inc.
  • Spark Therapeutics, Inc.
  • UniQure N.V.
  • Vericel Corporation

Table Information